EyePoint, Inc. Fair Value Inputs, Control Premium (Deprecated 2018-01-31)
EyePoint, Inc. (EYPT) reported Fair Value Inputs, Control Premium (Deprecated 2018-01-31) of 15.00% for the 12-month period ending 2011-12-31, per its 10-K filed 2012-09-27.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueInputsControlPremium · last filed 2014-09-11
- EyePoint, Inc. fair value inputs, control premium (deprecated 2018-01-31) for fiscal 2011 was 15.00%.
| Period end | Fair Value Inputs, Control Premium (Deprecated 2018-01-31) 6 month | Fair Value Inputs, Control Premium (Deprecated 2018-01-31) 12 month |
|---|---|---|
| 2011-12-31 | 15.00% 10-K · filed 2014-09-11 | 15.00% 10-K · filed 2012-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |